Stratec SE (SBS) - Total Liabilities
Based on the latest financial reports, Stratec SE (SBS) has total liabilities worth €191.16 Million EUR (≈ $223.48 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore SBS cash flow metrics to assess how effectively this company generates cash.
Stratec SE - Total Liabilities Trend (2002–2024)
This chart illustrates how Stratec SE's total liabilities have evolved over time, based on quarterly financial data. Check asset resilience ratio of Stratec SE to evaluate the company's liquid asset resilience ratio.
Stratec SE Competitors by Total Liabilities
The table below lists competitors of Stratec SE ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Cogelec SA
PA:ALLEC
|
France | €95.77 Million |
|
Deo Ca Traffic Infrastructure Investment JSC
VN:HHV
|
Vietnam | ₫28.01 Trillion |
|
Caxton
JSE:CAT
|
South Africa | ZAC1.84 Billion |
|
The E&M Co. Ltd
KQ:089230
|
Korea | ₩54.21 Billion |
|
Chorokbaem Healthcare Co Ltd
KO:118000
|
Korea | ₩76.98 Billion |
|
First United Corporation
NASDAQ:FUNC
|
USA | $1.88 Billion |
|
DCX Systems Limited
NSE:DCXINDIA
|
India | Rs6.45 Billion |
|
Mitrabahtera Segara Sejati Tbk
JK:MBSS
|
Indonesia | Rp23.93 Million |
Liability Composition Analysis (2002–2024)
This chart breaks down Stratec SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Stratec SE.
Liquidity & Leverage Metrics
Key Metrics Explained
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 4.19 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.80 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.44 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Stratec SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Stratec SE (2002–2024)
The table below shows the annual total liabilities of Stratec SE from 2002 to 2024.
| Year | Total Liabilities | Change |
|---|---|---|
| 2024-12-31 | €202.53 Million ≈ $236.77 Million |
-13.17% |
| 2023-12-31 | €233.25 Million ≈ $272.70 Million |
+35.36% |
| 2022-12-31 | €172.32 Million ≈ $201.46 Million |
+5.87% |
| 2021-12-31 | €162.77 Million ≈ $190.29 Million |
+2.14% |
| 2020-12-31 | €159.36 Million ≈ $186.31 Million |
+13.50% |
| 2019-12-31 | €140.41 Million ≈ $164.15 Million |
+14.08% |
| 2018-12-31 | €123.08 Million ≈ $143.89 Million |
+16.18% |
| 2017-12-31 | €105.94 Million ≈ $123.85 Million |
-7.27% |
| 2016-12-31 | €114.25 Million ≈ $133.57 Million |
+298.65% |
| 2015-12-31 | €28.66 Million ≈ $33.51 Million |
+11.53% |
| 2014-12-31 | €25.70 Million ≈ $30.04 Million |
+24.69% |
| 2013-12-31 | €20.61 Million ≈ $24.09 Million |
-30.97% |
| 2012-12-31 | €29.85 Million ≈ $34.90 Million |
+7.52% |
| 2011-12-31 | €27.77 Million ≈ $32.46 Million |
+3.00% |
| 2010-12-31 | €26.96 Million ≈ $31.52 Million |
+1.73% |
| 2009-12-31 | €26.50 Million ≈ $30.98 Million |
+32.07% |
| 2008-12-31 | €20.06 Million ≈ $23.46 Million |
+9.67% |
| 2007-12-31 | €18.29 Million ≈ $21.39 Million |
+7.70% |
| 2006-12-31 | €16.99 Million ≈ $19.86 Million |
+40.33% |
| 2005-12-31 | €12.10 Million ≈ $14.15 Million |
+19.05% |
| 2004-12-31 | €10.17 Million ≈ $11.89 Million |
-6.63% |
| 2003-12-31 | €10.89 Million ≈ $12.73 Million |
+106174.34% |
| 2002-12-31 | €10.25K ≈ $11.98K |
-- |
About Stratec SE
Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation… Read more